Percutaneous microwave ablation of bone tumors: a systematic review.
Bone
Microwaves
Neoplasms
Pain
Safety
Journal
European radiology
ISSN: 1432-1084
Titre abrégé: Eur Radiol
Pays: Germany
ID NLM: 9114774
Informations de publication
Date de publication:
May 2021
May 2021
Historique:
received:
17
05
2020
accepted:
06
10
2020
revised:
21
08
2020
pubmed:
7
11
2020
medline:
16
4
2021
entrez:
6
11
2020
Statut:
ppublish
Résumé
To systematically review microwave ablation (MWA) protocols, safety, and clinical efficacy for treating bone tumors. A systematic literature search was conducted using PubMed, the Cochrane Library, EMBASE, and Web of Science database. Data concerning patient demographics, tumor characteristics, procedure, complications, and clinical outcomes were extracted and analyzed. Seven non-comparative studies (6 retrospective, 1 prospective) were included accounting for 249 patients and 306 tumors (244/306 [79.7%] metastases; 25/306 [8.2%] myelomas, and 37/306 [12.1%] osteoid osteomas [OO]). In malignant tumors, MWA power was 30-70 W (except in one spinal tumors series where a mean power of 13.3 W was used) with pooled mean ablation time of 308.3 s. With OO, MWA power was 30-60 W with mean ablation time of 90-102 s. Protective measures were very sporadically used in 5 studies. Additional osteoplasty was performed in 199/269 (74.0%) malignant tumors. Clinically significant complications were noted in 10/249 (4.0%) patients. For malignant tumors, estimated pain reduction on the numerical rating scale was 5.3/10 (95% confidence intervals [95%CI] 4.6-6.1) at 1 month; and 5.3/10 (95% CI 4.3-6.3) at the last recorded follow-up (range 20-24 weeks in 4/5 studies). For OO, at 1-month follow-up, effective pain relief was noted in 92.3-100% of patients. MWA is effective in achieving pain relief at short- (1 month) and mid-term (4-6 months) for painful OO and malignant bone tumors, respectively. Although MWA seems safe, further prospective studies are warranted to further assess this aspect, and to standardize MWA protocols. • Large heterogeneity exists across literature about ablation protocols used with microwave ablation applied for the treatment of benign and malignant bone tumors. • Although microwave ablation of bone tumors appears safe, further studies are needed to assess this aspect, as current literature does not allow definitive conclusions. • Nevertheless, microwave ablation is effective in achieving pain relief at short- (1 month) and mid-term (4-6 months) for painful osteoid osteomas and malignant bone tumors, respectively.
Identifiants
pubmed: 33155107
doi: 10.1007/s00330-020-07382-8
pii: 10.1007/s00330-020-07382-8
doi:
Types de publication
Journal Article
Review
Systematic Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
3530-3541Références
Coleman RE (2001) Metastatic bone disease: clinical features, pathophysiology and treatment strategies. Cancer Treat Rev 27(3):165–176
doi: 10.1053/ctrv.2000.0210
Macedo F, Ladeira K, Pinho F et al (2017) Bone metastases: an overview. Oncol Rev 11(1):321
pubmed: 28584570
pmcid: 5444408
Cazzato RL, Arrigoni F, Boatta E et al (2019) Percutaneous management of bone metastases: state of the art, interventional strategies and joint position statement of the Italian College of MSK Radiology (ICoMSKR) and the Italian College of Interventional Radiology (ICIR). Radiol Med 124(1):34–49
doi: 10.1007/s11547-018-0938-8
Gangi A, Tsoumakidou G, Buy X, Quoix E (2010) Quality improvement guidelines for bone tumour management. Cardiovasc Intervent Radiol 33(4):706–713
doi: 10.1007/s00270-009-9738-9
Koch G, Cazzato RL, Gilkison A, Caudrelier J, Garnon J, Gangi A (2018) Percutaneous treatments of benign bone tumors. Semin Intervent Radiol 35(4):324–332
doi: 10.1055/s-0038-1673640
Rehnitz C, Sprengel SD, Lehner B et al (2012) CT-guided radiofrequency ablation of osteoid osteoma and osteoblastoma: clinical success and long-term follow up in 77 patients. Eur J Radiol 81(11):3426–3434
doi: 10.1016/j.ejrad.2012.04.037
Miyazaki M, Arai Y, Myoui A et al (2016) Phase I/II multi-institutional study of percutaneous radiofrequency ablation for painful osteoid osteoma (JIVROSG-0704). Cardiovasc Intervent Radiol 39(10):1464–1470
doi: 10.1007/s00270-016-1438-7
Tanigawa N, Arai Y, Yamakado K et al (2018) Phase I/II study of radiofrequency ablation for painful bone metastases: Japan interventional radiology in oncology study group 0208. Cardiovasc Intervent Radiol 41(7):1043–1048
doi: 10.1007/s00270-018-1944-x
Goetz MP, Callstrom MR, Charboneau JW et al (2004) Percutaneous image-guided radiofrequency ablation of painful metastases involving bone: a multicenter study. J Clin Oncol 22(2):300–306
doi: 10.1200/JCO.2004.03.097
Cazzato RL, Garnon J, Caudrelier J, Rao PP, Koch G, Gangi A (2018) Percutaneous radiofrequency ablation of painful spinal metastasis: a systematic literature assessment of analgesia and safety. Int J Hyperthermia 34(8):1–10
Callstrom MR, Dupuy DE, Solomon SB et al (2013) Percutaneous image-guided cryoablation of painful metastases involving bone: multicenter trial. Cancer. 119(5):1033–1041
doi: 10.1002/cncr.27793
Santiago E, Pauly V, Brun G, Guenoun D, Champsaur P, Le Corroller T (2018) Percutaneous cryoablation for the treatment of osteoid osteoma in the adult population. Eur Radiol 28(6):2336–2344
doi: 10.1007/s00330-017-5164-6
Whitmore MJ, Hawkins CM, Prologo JD et al (2016) Cryoablation of osteoid osteoma in the pediatric and adolescent population. J Vasc Interv Radiol 27(2):232–237 quiz 238
doi: 10.1016/j.jvir.2015.10.005
Brace CL (2009) Microwave ablation technology: what every user should know. Curr Probl Diagn Radiol 38(2):61–67
doi: 10.1067/j.cpradiol.2007.08.011
Cazzato RL, De Marini P, Leclerc L et al (2020) Large nearly spherical ablation zones are achieved with simultaneous multi-antenna microwave ablation applied to treat liver tumours. Eur Radiol 30(2):971–975
doi: 10.1007/s00330-019-06431-1
Pusceddu C, Melis L, Ballicu N et al (2018) Percutaneous microwave ablation under CT guidance for hepatocellular carcinoma: a single institutional experience. J Gastrointest Cancer 49(3):295–301
doi: 10.1007/s12029-017-9951-8
Ma S, Ding M, Li J et al (2017) Ultrasound-guided percutaneous microwave ablation for hepatocellular carcinoma: clinical outcomes and prognostic factors. J Cancer Res Clin Oncol 43(1):131–142
doi: 10.1007/s00432-016-2266-5
Alexander ES, Wolf FJ, Machan JT et al (2015) Microwave ablation of focal hepatic malignancies regardless of size: a 9-year retrospective study of 64 patients. Eur J Radiol 84(6):1083–1090
doi: 10.1016/j.ejrad.2015.02.027
Wei Z, Zhang K, Ye X et al (2015) Computed tomography-guided percutaneous microwave ablation combined with osteoplasty for palliative treatment of painful extraspinal bone metastases from lung cancer. Skeletal Radiol 44(10):1485–1490
doi: 10.1007/s00256-015-2195-4
Rinzler ES, Shivaram GM et al (2019) Microwave ablation of osteoid osteoma: initial experience and efficacy. Pediatr Radiol 49(4):566–570
doi: 10.1007/s00247-018-4327-1
Pusceddu C, Sotgia B, Fele RM, Ballicu N, Melis L (2016) Combined microwave ablation and cementoplasty in patients with painful bone metastases at high risk of fracture. Cardiovasc Intervent Radiol 39(1):74–80
doi: 10.1007/s00270-015-1151-y
Prud’homme C, Nueffer JP, Runge M, Dubut J, Kastler B, Aubry S (2017) Prospective pilot study of CT-guided microwave ablation in the treatment of osteoid osteomas. Skeletal Radiol 46(3):315–323
doi: 10.1007/s00256-016-2558-5
Khan MA, Deib G, Deldar B, Patel AM, Barr JS (2018) Efficacy and safety of percutaneous microwave ablation and cementoplasty in the treatment of painful spinal metastases and myeloma. AJNR Am J Neuroradiol 39(7):1376–1383
doi: 10.3174/ajnr.A5680
Kastler A, Alnassan H, Aubry S, Kastler B (2014) Microwave thermal ablation of spinal metastatic bone tumors. J Vasc Interv Radiol 25(9):1470–1475
doi: 10.1016/j.jvir.2014.06.007
Deib G, Deldar B, Hui F, Barr JS, Khan MA (2019) Percutaneous microwave ablation and cementoplasty: clinical utility in the treatment of painful extraspinal osseous metastatic disease and myeloma. AJR Am J Roentgenol. https://doi.org/10.2214/AJR.18.20386
Auloge P, Cazzato RL, Rousseau C et al (2019) Complications of percutaneous bone tumor cryoablation: a 10-year experience. Radiology. 291(2):521–528
doi: 10.1148/radiol.2019181262
Cazzato RL, Palussière J, Auloge P et al (2020) Complications following percutaneous image-guided radiofrequency ablation of bone tumors: a 10-year dual-center experience. Radiology. 296(1):227–235
doi: 10.1148/radiol.2020191905
Slim K, Nini E, Forestier D, Kwiatkowski F, Panis Y, Chipponi J (2003) Methodological index for non-randomized studies (minors): development and validation of a new instrument. ANZ J Surg 73(9):712–716
doi: 10.1046/j.1445-2197.2003.02748.x
Rosenthal DI, Hornicek FJ, Torriani M, Gebhardt MC, Mankin HJ (2003) Osteoid osteoma: percutaneous treatment with radiofrequency energy. Radiology. 229(1):171–175
doi: 10.1148/radiol.2291021053
Gennaro N, Sconfienza LM, Ambrogi F, Boveri S, Lanza E (2019) Thermal ablation to relieve pain from metastatic bone disease: a systematic review. Skeletal Radiol 48(8):1161–1169
doi: 10.1007/s00256-018-3140-0
Tsoumakidou G, Thénint MA, Garnon J, Buy X, Steib JP, Gangi A (2016) Percutaneous image-guided laser photocoagulation of spinal osteoid osteoma: a single-institution series. Radiology. 278(3):936–943
doi: 10.1148/radiol.2015150491
Thacker PG, Callstrom MR, Curry TB et al (2011) Palliation of painful metastatic disease involving bone with imaging-guided treatment: comparison of patients’ immediate response to radiofrequency ablation and cryoablation. AJR Am J Roentgenol 197(2):510–515
doi: 10.2214/AJR.10.6029